Skip to content
Category Hero Image image 35

Execute Clinical Trial Feasibility with Precision

Optimize your study's initiation through precise country and site selection, powered by actionable insights.
At Precision, our feasibility process is more than just a preliminary step; it's a critical foundation for the success of your clinical trial. By focusing on strategic site selection and in-depth insights gathering, we ensure your study starts with a significant advantage. 
iStock-876250496

Plan for success with Site Feasibility

Site feasibility is the cornerstone of clinical trial planning, acting as the bridge between groundbreaking research and its successful execution. Understanding the pivotal role of site feasibility ensures a solid foundation for any clinical study. It's not merely about identifying potential sites but about strategic alignment with the trial's objectives, patient populations, and operational capacities. This proactive approach to site selection, grounded in data-driven insights and comprehensive evaluations, mitigates risks and sets the stage for successful patient enrollment and study outcomes.

Roughly 80% of clinical trials fail to meet original enrollment timelines, and about one-third of Phase III study terminations are due to enrollment difficulties. Additionally, 15% to 20% of sites never enroll a single patient.

Given these statistics, it's evident that conducting a comprehensive feasibility study is essential for avoiding common pitfalls like poor enrollment and sites that never enroll.  Precision's feasibility team employs multiple methods to ensure a sponsor's needs are met, tailoring our approach to each unique trial. This adaptability, combined with a deep understanding of the intricacies of clinical trials, allows Precision to navigate complex requirements and ensure trials are set up for success from the start.

Precision's Clinical Trial Feasibility process overview

Step 1

Initial Planning
  • Understand study objectives
  • Identify target countries/sites
  • Develop feasibility questionnaire
  • Augment site list with Precision/external data
  • Site list finalized for feasibility start

Step 2

Data Collection & Analysis
  • Distribute questionnaires
  • Pursue sites for response
  • Collect sites responses
  • Evaluate sites performance
  • Prepare feasibility report
  • Review report with client
  • Filter out low-potential sites

Step 3

Recruitment Modeling
  • Develop enrollment scenarios
  • Estimate recruitment timelines
  • Project patient numbers
  • Adjust site requirements
  • Plan for contingencies
  • Present models to clients

Step 4

Site Selection & Verification
  • Confirm top-performing sites
  • Schedule pre-study visits
  • Verify site infrastructure
  • Assess staff expertise
  • Determine recruitment potential
  • Finalize site list for activation
  • Finalize back-up site list

Step 5

Performance Monitoring
  • Regular progress check-ins
  • Address emerging issues
  • Adjust recruitment plans
  • Activate backup sites
  • Ensure timeline adherence
  • Provide ongoing support

Precision’s strategic approach to clinical trial feasibility

Our approach to site feasibility is both comprehensive and meticulous. By integrating broad data analysis with site-specific insights, we ensure each trial starts on the best possible footing. Our process begins with understanding study objectives and identifying optimal countries and sites, followed by developing and distributing targeted feasibility questionnaires. We then analyze site responses and performance, preparing detailed feasibility reports for client review. Through recruitment modeling, we project patient numbers and timelines, allowing for adjustments and contingency planning. Site selection is confirmed through pre-study visits and infrastructure verification, with backup sites identified for risk mitigation. Continuous performance monitoring ensures adherence to timelines and proactive issue resolution, backed by ongoing support. This strategic and detailed approach enables our sponsors to navigate trial complexities with confidence, ensuring successful study execution.

Our site feasibility services can be executed as standalone projects, during pre-study phases, or integrated into full study start-up processes. This flexibility allows us to adapt to each sponsor's unique requirements, providing tailored support that aligns with their specific clinical trial needs.

Insights from Precision’s experts

Stay ahead with the latest insights from Precision’s team of experts. Discover valuable perspectives, updates, and strategies to navigate early and late phase development. 

Read: 2025 Biotech Economics: CROs, Advanced Therapies & Trends in Funding 2025 Biotech Economics: CROs, Advanced Therapies & Trends in Funding

Clinical Trials - Early Phase Research

2025 Biotech Economics: CROs, Advanced Therapies & Trends in Funding

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=159488778858, hs_child_table_id=0, hs_updated_at=1741014116242, hs_published_at=1741014119284, description=Rob Maiale is a marketing strategist and creative technologist known for shaping content strategies that drive engagement, influence, and business impact. With more than 15 years of experience spanning clinical research, patient education, pharma, and diagnostics, he specializes in turning expert insights into market-shaping narratives. At Precision, Rob leads innovative storytelling initiatives that connect cutting-edge science with the right audiences—leveraging AI, emerging technologies, and deep industry expertise to keep content ahead of the curve., avatar=Image{width=400,height=400,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Rob%20Maiale.jpg',altText='Rob Maiale',fileId=184765575245}, linkedin=https://www.linkedin.com/in/rob-maiale/, hs_name=, hs_path=, lastname=Maiale, hs_initial_published_at=1741014119343, hs_created_at=1709645745089, hs_is_edited=false, hs_deleted_at=0, name=Rob, job=, slug=rob-maiale, email=, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Rob Maiale avatar

    Rob Maiale

Discover
Read: FDA's Project Optimus: What Pharma and Biotech Need to Know FDA's Project Optimus: What Pharma and Biotech Need to Know

Clinical Trials - Regulatory

FDA's Project Optimus: What Pharma and Biotech Need to Know

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=167363064857, hs_child_table_id=0, hs_updated_at=1719905898183, hs_published_at=1741014119284, description=Industry-leading oncologist and demonstrated medical leader in precision medicine, novel trial design and innovative regulatory initiatives designed to expedite drug approvals. Draws on nearly a decade leading oncology and rare disease programs at the FDA. Former fellow at the National Cancer Institute and frequent featured speaker at ASCO and AACR. CDER technical authority on oncologic drug and biological products for thoracic and head and neck malignancies, neurologic tumors, pediatric solid tumors and rare tumors., avatar=Image{width=553,height=580,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Harpreet-Singh2.png',altText='Harpreet-Singh2',fileId=171747124346}, linkedin=https://www.linkedin.com/in/harpreetsinghmd/, team=[{id=163072475007, name='Precision for Medicine Leadership'}], lastname=Singh, MD, hs_initial_published_at=1715692570942, hs_created_by_user_id=2737751, hs_created_at=1715692477118, hs_is_edited=false, hs_deleted_at=0, name=Harpreet, job=Chief Medical Officer, slug=harpreet-singh, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Harpreet Singh, MD avatar

    Harpreet Singh, MD

Discover
Read: Case Study Phase 3 NSCLC: Site Relationships Streamline Feasibility Case Study Phase 3 NSCLC: Site Relationships Streamline Feasibility

Clinical Trials

Case Study Phase 3 NSCLC: Site Relationships Streamline Feasibility

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=185838258545, hs_child_table_id=0, hs_updated_at=1738849388884, hs_published_at=1741014119284, description=Anna Rodecki is a results driven leader with 24 years of experience in clinical research across the pharmaceutical, device, and biotech industries. She has played a pivotal role in shaping clinical development plans on both Sponsor and CRO, successfully supporting First- In-Human (FIH) – Phase IV trials successfully across various therapeutics areas. Anan thrives on building strong, collaborative teams fostering innovation. Her expertise spans strategic planning, risk management, inspection readiness and cross-functional leadership – always with a focus on improving patient outcomes and advancing the future of medicine., avatar=Image{width=1200,height=1200,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Anna%20Rodecki.png',altText='Anna Rodecki',fileId=185842773784}, lastname=Rodecki, hs_initial_published_at=1738849393727, hs_created_by_user_id=26433386, hs_created_at=1738849349748, hs_is_edited=false, hs_deleted_at=0, name=Anna, job=Director, Project Management, slug=anna-rodecki, hs_updated_by_user_id=26433386}, second={}, third={}})
  • Anna Rodecki avatar

    Anna Rodecki

Discover

Advance therapeutic breakthroughs with Precision

Explore the breadth of our expertise in therapeutics and modalities, as we lead your novel treatments in Oncology, Rare Diseases and beyond, from the groundbreaking idea to clinical realization.

Clinical trial excellence: Precision in all phases

With people across 70+ countries, our team provides comprehensive clinical trial services that streamline and accelerate drug development at a global scale

  • Explore

    Early Phase Excellence

    Embark on the critical first steps of clinical discovery with our expertly managed early phase trials, where meticulous attention meets innovative strategy.
    Explore
  • Explore

    Late Phase Success

    Discover the path to market with our Late Phase Development expertise – delivering precision, scale, and efficiency for your clinical journey.
    Explore

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to increase speed to market. Incorporate manufacturing expertise for advances therapies to ensure scalability. Precision can customize and converge our capabilities for your program's unique needs.

  • Discover Explore
    clinical-trial-support

    Global CRO
    Services

    Award-winning CRO with deep oncology and rare disease expertise

    Explore
  • Discover Explore
    specialty-lab-services

    Global Laboratory
    Services

    Exceptional translational and biomarker sciences with global central lab services

    Explore
  • Discover Explore
    Manufacturing

    Manufacturing
    Solutions

    Pioneers in planning, building and maintaining manufacturing at scale for pharma and biotechs.

    Explore